Idorsia Financial Statements From 2010 to 2024

IDIA Stock  CHF 0.77  0.02  2.67%   
Idorsia financial statements provide useful quarterly and yearly information to potential Idorsia investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Idorsia financial statements helps investors assess Idorsia's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Idorsia's valuation are summarized below:
Idorsia does not presently have any fundamental trends for analysis.
Check Idorsia financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Idorsia's main balance sheet or income statement drivers, such as , as well as many indicators such as . Idorsia financial statements analysis is a perfect complement when working with Idorsia Valuation or Volatility modules.
  
This module can also supplement various Idorsia Technical models . Check out the analysis of Idorsia Correlation against competitors.

Idorsia Company Operating Margin Analysis

Idorsia's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Idorsia Operating Margin

    
  (8.25) %  
Most of Idorsia's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Idorsia is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Idorsia has an Operating Margin of -8.2518%. This is 76.48% lower than that of the Healthcare sector and 92.64% lower than that of the Biotechnology industry. The operating margin for all Switzerland stocks is 49.76% higher than that of the company.

Idorsia Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Idorsia's current stock value. Our valuation model uses many indicators to compare Idorsia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Idorsia competition to find correlations between indicators driving Idorsia's intrinsic value. More Info.
Idorsia is rated second overall in return on equity category among its peers. It is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Idorsia's earnings, one of the primary drivers of an investment's value.

About Idorsia Financial Statements

Idorsia investors use historical fundamental indicators, such as Idorsia's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Idorsia. Please read more on our technical analysis and fundamental analysis pages.
Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland. Idorsia Ltd is traded on Switzerland Exchange in Switzerland.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Idorsia Stock Analysis

When running Idorsia's price analysis, check to measure Idorsia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Idorsia is operating at the current time. Most of Idorsia's value examination focuses on studying past and present price action to predict the probability of Idorsia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Idorsia's price. Additionally, you may evaluate how the addition of Idorsia to your portfolios can decrease your overall portfolio volatility.